"Macrophage PD-L1 strikes back: PD-1/PD-L1 interaction drives macrophages toward regulatory subsets"
written by Yun-Jung Lee, Young-Hye Moon, Kyeong Eun Hyung, Jong-Sun Yoo, Mi Ji Lee, Ik Hee Lee, Byung Sung Go, Kwang Woo Hwang,
published by Advances in Bioscience and Biotechnology, Vol.4 No.8C, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Dexmedetomidine Mitigates Microglia-Mediated Neuroinflammation through Upregulation of Programmed Cell Death Protein 1 in a Rat Spinal Cord Injury Model
[2] Limited activity of metronomic cyclophosphamide and pembrolizumab for soft tissue sarcomas
Translational gastroenterology and hepatology, 2018
[3] PD-L1 immunostaining scoring for non-small cell lung cancer based on immunosurveillance parameters
PLOS ONE, 2018
[4] Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation
[5] Therapeutically exploiting STAT3 activity in cancer—using tissue repair as a road map
[6] Folate Receptor Beta as a Marker of Immunosupressive Myeloid Derived Suppressor Cells and Tumor Associated Macrophages in the Tumor Microenvironment
[7] PD-L1 expression by tumor macrophages: regulation and signaling
[8] Aging and cancer: The role of macrophages and neutrophils
Ageing Research Reviews, 2017
[9] Dynamic changes in PD-L1 expression and immune infiltrates early during treatment predict response to PD-1 blockade in melanoma
[10] Rapid generation of Col7a1−/− mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal …
Laboratory Investigation, 2017
[11] MiR‐16 regulates mouse peritoneal macrophage polarization and affects T‐cell activation
Journal of cellular and molecular medicine, 2016
[12] Bioanalytical qualification of clinical biomarker assays in plasma using a novel multi-analyte Simple Plex™ platform
[13] Regulation of neuroinflammation through programed death-1/programed death ligand signaling in neurological disorders
Frontiers in cellular neuroscience, 2014